Martinez-Garcia et al developed a score to determine the severity of non-cystic bronchiectasis. This can help to identify a patient who may require more aggressive management. The authors are from multiple hospitals in Spain.
The name FACED is derived from the 5 parameters found significant on logistic regression.
Patient selection: non-cystic bronchiectasis
Parameters:
(1) age of the patient in years (A)
(2) FEV1 as percent of predicted (F)
(3) dyspnea on the mMRC scale (D)
(4) number of lobes affected (extent, E)
(5) chronic colonization with Pseudomonas aeruginosa (C)
|
Parameter |
Finding |
Points |
|
age of the patient |
< 70 years |
0 |
|
|
>= 70 years |
2 |
|
FEV1 |
>= 50% of predicted |
0 |
|
|
< 50% of predicted |
2 |
|
dyspnea on mMRC scale |
0, I, II |
0 |
|
|
III or IV |
1 |
|
number of lobes affected |
1 or 2 |
0 |
|
|
>= 3 |
1 |
|
colonization with Pseudomonas |
absent |
0 |
|
|
present |
1 |
total score =
= SUM(points for all 5 parameters)
Interpretation:
• minimum score: 0
• maximum score: 7
• The higher the score the more severe the bronchiectasis.
|
Total Score |
Severity |
5-Year Survival |
|
0 to 2 |
mild |
98-99% |
|
3 or 4 |
moderate |
85% |
|
5 to 7 |
severe |
48-54% |
Specialty: Pulmonology
